Annual revenue:
$426.45M+$168.24M(+65.15%)Summary
- As of today (May 8, 2025), ADMA annual revenue is $426.45 million, with the most recent change of +$168.24 million (+65.15%) on December 31, 2024.
- During the last 3 years, ADMA annual revenue has risen by +$345.51 million (+426.86%).
- ADMA annual revenue is now at all-time high.
Performance
ADMA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$117.55M-$2.29M(-1.91%)Summary
- As of today (May 8, 2025), ADMA quarterly revenue is $117.55 million, with the most recent change of -$2.29 million (-1.91%) on December 31, 2024.
- Over the past year, ADMA quarterly revenue has increased by +$43.65 million (+59.06%).
- ADMA quarterly revenue is now -1.91% below its all-time high of $119.84 million, reached on September 30, 2024.
Performance
ADMA Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$426.45M+$43.65M(+11.40%)Summary
- As of today (May 8, 2025), ADMA TTM revenue is $426.45 million, with the most recent change of +$43.65 million (+11.40%) on December 31, 2024.
- Over the past year, ADMA TTM revenue has increased by +$168.24 million (+65.15%).
- ADMA TTM revenue is now at all-time high.
Performance
ADMA TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ADMA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +65.2% | +59.1% | +65.2% |
| 3 y3 years | +426.9% | +345.5% | +426.9% |
| 5 y5 years | +1353.0% | +876.6% | +1083.9% |
ADMA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +426.9% | -1.9% | +303.9% | at high | +353.7% |
| 5 y | 5-year | at high | +1353.0% | -1.9% | +1409.4% | at high | +1083.9% |
| alltime | all time | at high | >+9999.0% | -1.9% | >+9999.0% | at high | >+9999.0% |
ADMA Biologics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $426.45M(+65.2%) | $117.55M(-1.9%) | $426.45M(+11.4%) |
| Sep 2024 | - | $119.84M(+11.8%) | $382.81M(+15.9%) |
| Jun 2024 | - | $107.19M(+30.9%) | $330.25M(+16.6%) |
| Mar 2024 | - | $81.88M(+10.8%) | $283.18M(+9.7%) |
| Dec 2023 | $258.21M(+67.6%) | $73.90M(+9.9%) | $258.22M(+10.2%) |
| Sep 2023 | - | $67.28M(+11.9%) | $234.29M(+12.6%) |
| Jun 2023 | - | $60.12M(+5.6%) | $208.11M(+14.4%) |
| Mar 2023 | - | $56.91M(+13.9%) | $181.89M(+18.0%) |
| Dec 2022 | $154.08M(+90.4%) | $49.98M(+21.6%) | $154.08M(+18.1%) |
| Sep 2022 | - | $41.09M(+21.2%) | $130.48M(+18.5%) |
| Jun 2022 | - | $33.91M(+16.5%) | $110.07M(+17.1%) |
| Mar 2022 | - | $29.10M(+10.3%) | $94.00M(+16.1%) |
| Dec 2021 | $80.94M(+91.7%) | $26.38M(+27.6%) | $80.94M(+18.1%) |
| Sep 2021 | - | $20.68M(+16.0%) | $68.52M(+17.9%) |
| Jun 2021 | - | $17.83M(+11.1%) | $58.11M(+20.9%) |
| Mar 2021 | - | $16.05M(+15.0%) | $48.07M(+13.9%) |
| Dec 2020 | $42.22M(+43.9%) | $13.96M(+35.8%) | $42.22M(+4.8%) |
| Sep 2020 | - | $10.28M(+32.0%) | $40.30M(+8.2%) |
| Jun 2020 | - | $7.79M(-23.6%) | $37.25M(+3.4%) |
| Mar 2020 | - | $10.20M(-15.3%) | $36.02M(+22.7%) |
| Dec 2019 | $29.35M(+72.8%) | $12.04M(+66.7%) | $29.35M(+37.3%) |
| Sep 2019 | - | $7.22M(+10.1%) | $21.37M(+16.3%) |
| Jun 2019 | - | $6.56M(+85.9%) | $18.38M(+11.6%) |
| Mar 2019 | - | $3.53M(-13.0%) | $16.47M(-3.0%) |
| Dec 2018 | $16.99M | $4.06M(-4.1%) | $16.99M(-31.9%) |
| Sep 2018 | - | $4.23M(-9.2%) | $24.93M(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $4.66M(+15.2%) | $25.43M(+5.2%) |
| Mar 2018 | - | $4.04M(-66.3%) | $24.17M(+6.2%) |
| Dec 2017 | $22.76M(+113.5%) | $12.00M(+153.8%) | $22.76M(+61.6%) |
| Sep 2017 | - | $4.73M(+39.1%) | $14.09M(+14.6%) |
| Jun 2017 | - | $3.40M(+29.3%) | $12.29M(+10.1%) |
| Mar 2017 | - | $2.63M(-21.0%) | $11.17M(+4.7%) |
| Dec 2016 | $10.66M(+48.5%) | $3.33M(+13.3%) | $10.66M(+8.3%) |
| Sep 2016 | - | $2.94M(+29.3%) | $9.85M(+12.4%) |
| Jun 2016 | - | $2.27M(+7.0%) | $8.76M(+12.3%) |
| Mar 2016 | - | $2.12M(-15.5%) | $7.80M(+8.6%) |
| Dec 2015 | $7.18M(+21.3%) | $2.51M(+35.6%) | $7.18M(+16.6%) |
| Sep 2015 | - | $1.85M(+41.4%) | $6.15M(+8.6%) |
| Jun 2015 | - | $1.31M(-12.9%) | $5.67M(-3.3%) |
| Mar 2015 | - | $1.50M(+1.0%) | $5.86M(-1.0%) |
| Dec 2014 | $5.92M(+92.8%) | $1.49M(+9.0%) | $5.92M(+21.9%) |
| Sep 2014 | - | $1.37M(-9.0%) | $4.85M(+5.6%) |
| Jun 2014 | - | $1.50M(-3.9%) | $4.59M(+19.7%) |
| Mar 2014 | - | $1.56M(+268.1%) | $3.84M(+25.0%) |
| Dec 2013 | $3.07M(+174.4%) | $424.00K(-61.7%) | $3.07M(-3.1%) |
| Sep 2013 | - | $1.11M(+49.0%) | $3.17M(+30.9%) |
| Jun 2013 | - | $743.30K(-6.3%) | $2.42M(+26.9%) |
| Mar 2013 | - | $792.90K(+51.5%) | $1.91M(+70.5%) |
| Dec 2012 | $1.12M | $523.30K(+45.2%) | $1.12M(+88.0%) |
| Sep 2012 | - | $360.30K(+56.6%) | $594.80K(+153.6%) |
| Jun 2012 | - | $230.10K(+5129.5%) | $234.50K(+5229.5%) |
| Mar 2012 | - | $4400.00 | $4400.00 |
FAQ
- What is ADMA Biologics annual revenue?
- What is the all time high annual revenue for ADMA Biologics?
- What is ADMA Biologics annual revenue year-on-year change?
- What is ADMA Biologics quarterly revenue?
- What is the all time high quarterly revenue for ADMA Biologics?
- What is ADMA Biologics quarterly revenue year-on-year change?
- What is ADMA Biologics TTM revenue?
- What is the all time high TTM revenue for ADMA Biologics?
- What is ADMA Biologics TTM revenue year-on-year change?
What is ADMA Biologics annual revenue?
The current annual revenue of ADMA is $426.45M
What is the all time high annual revenue for ADMA Biologics?
ADMA Biologics all-time high annual revenue is $426.45M
What is ADMA Biologics annual revenue year-on-year change?
Over the past year, ADMA annual revenue has changed by +$168.24M (+65.15%)
What is ADMA Biologics quarterly revenue?
The current quarterly revenue of ADMA is $117.55M
What is the all time high quarterly revenue for ADMA Biologics?
ADMA Biologics all-time high quarterly revenue is $119.84M
What is ADMA Biologics quarterly revenue year-on-year change?
Over the past year, ADMA quarterly revenue has changed by +$43.65M (+59.06%)
What is ADMA Biologics TTM revenue?
The current TTM revenue of ADMA is $426.45M
What is the all time high TTM revenue for ADMA Biologics?
ADMA Biologics all-time high TTM revenue is $426.45M
What is ADMA Biologics TTM revenue year-on-year change?
Over the past year, ADMA TTM revenue has changed by +$168.24M (+65.15%)